106 related articles for article (PubMed ID: 17436601)
1. Optimizing the gonadotrophin dose regimen.
Out HJ; Thomas LE
Int Surg; 2006; 91(5 Suppl):S15-24. PubMed ID: 17436601
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
4. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.
Corifollitropin Alfa Dose-finding Study Group
Hum Reprod; 2008 Nov; 23(11):2484-92. PubMed ID: 18684735
[TBL] [Abstract][Full Text] [Related]
5. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
6. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone.
Leader A;
Fertil Steril; 2006 Jun; 85(6):1766-73. PubMed ID: 16759926
[TBL] [Abstract][Full Text] [Related]
7. [Results of application of high daily doses of recombinant follicle stimulating hormone in different age groups of women in IVF program].
Tsagareishvili GG; Khonelidze NL; Lazarev AP
Georgian Med News; 2005 Jun; (123):7-12. PubMed ID: 16052045
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: A prospective randomized, double blind clinical trial.
Pruksananonda K; Suwajanakorn S; Sereepapong W; Virutamasen P
J Med Assoc Thai; 2004 Oct; 87(10):1151-5. PubMed ID: 15560689
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
10. PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.
Yovich JL; Alsbjerg B; Conceicao JL; Hinchliffe PM; Keane KN
Drug Des Devel Ther; 2016; 10():2561-73. PubMed ID: 27563236
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin.
Al-Inany H; Aboulghar MA; Mansour RT; Serour GI
Gynecol Endocrinol; 2005 Mar; 20(3):161-9. PubMed ID: 16019356
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
15. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
Orvieto R; Homburg R
Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
[TBL] [Abstract][Full Text] [Related]
16. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles.
Out HJ; David I; Ron-El R; Friedler S; Shalev E; Geslevich J; Dor J; Shulman A; Ben-Rafael Z; Fisch B; Dirnfeld M
Hum Reprod; 2001 Jun; 16(6):1104-9. PubMed ID: 11387277
[TBL] [Abstract][Full Text] [Related]
20. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]